tripalmitin has been researched along with caprylates in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lemmen, C; Lemmen, P; Stuhler, K; Wolfram, G | 1 |
| CHAIKOFF, IL; LOSSOW, WJ | 1 |
| Amore, E; Augello, G; Bondì, ML; Botto, C; Cervello, M; Craparo, EF; Emma, MR | 1 |
3 other study(ies) available for tripalmitin and caprylates
| Article | Year |
|---|---|
Utilization of medium-chain triglycerides and octanoic acid by cultured human fibroblasts and lymphoblasts.
Topics: Animals; Caprylates; Carbon Radioisotopes; Cells, Cultured; Cytochalasin B; Fibroblasts; Humans; Kinetics; Lymphocytes; Muscles; Oxidation-Reduction; Rats; Skin; Triglycerides | 1988 |
Secretion of intravenously administered tripalmitin-1-C14 and octanoate-1-C14 into milk by the lactating rat.
Topics: Animals; Caprylates; Fats; Fatty Acids; Female; Humans; Lactation; Lipid Metabolism; Milk; Rats; Triglycerides | 1958 |
Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells.
Topics: Antineoplastic Agents; Caprylates; Cell Survival; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Hemolysis; Hep G2 Cells; Humans; Lipids; Microscopy, Electron, Scanning; Nanoparticles; Niacinamide; Particle Size; Phenylurea Compounds; Sorafenib; Triglycerides | 2015 |